Results 211 to 220 of about 38,104 (229)

AMIODARONE AND THE THYROID

The Lancet, 1979
openaire   +2 more sources

The role of CYP3A4 in amiodarone-associated toxicity on HepG2 cells

Biochemical Pharmacology, 2011
Michael Torok, Stephan Krähenbühl
exaly  

Quantitative Overview of Randomized Trials of Amiodarone to Prevent Sudden Cardiac Death

Circulation, 1997
Ida Sim, Kathryn M Mcdonald, Philip W Lavori   +2 more
exaly  

Dose-Ranging Study of Intravenous Amiodarone in Patients With Life-Threatening Ventricular Tachyarrhythmias

Circulation, 1995
Melvin M Scheinman, David S Cannom, Edward V Platia   +2 more
exaly  

Amiodarone-induced pulmonary toxicity: an under-recognized and severe adverse effect?

Clinical Research in Cardiology, 2010
Martin Schwaiblmair, Wolfgang Von Scheidt, Von Scheidt Wolfgang   +2 more
exaly  

Randomised trial of low-dose amiodarone in severe congestive heart failure

Lancet, The, 1994
Hernán C Doval
exaly  

Clinical Experience and Grading of Amiodarone Keratopathy

Ophthalmology, 1984
Stephen F Schaal
exaly  

Electrophysiological effects of dronedarone (SR 33589), a noniodinated amiodarone derivative in the canine heart: comparison with amiodarone

British Journal of Pharmacology, 2001
Miklós Nemeth, László Virág, Norbert Iost   +2 more
exaly  

Serum concentrations of amiodarone during long term therapy. Relation to dose, efficacy and toxicity

European Journal of Clinical Pharmacology, 1983
J Bircher, H Studer, M Stäubli
exaly  

Prospective randomized study comparing amiodarone vs. amiodarone plus losartan vs. amiodarone plus perindopril for the prevention of atrial fibrillation recurrence in patients with lone paroxysmal atrial fibrillation

European Heart Journal, 2006
Y Yin, Darshan Dalal, Jinjin Wu
exaly